Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$0.53 - $1.14 $8,643 - $18,591
-16,308 Reduced 14.13%
99,081 $60,000
Q3 2023

Nov 14, 2023

BUY
$0.84 - $1.43 $45,300 - $77,118
53,929 Added 87.75%
115,389 $135,000
Q2 2023

Aug 11, 2023

SELL
$0.83 - $1.12 $1,610 - $2,172
-1,940 Reduced 3.06%
61,460 $54,000
Q1 2023

May 16, 2023

SELL
$0.91 - $1.69 $1,639 - $3,045
-1,802 Reduced 2.76%
63,400 $65,000
Q4 2022

Feb 14, 2023

BUY
$1.09 - $2.04 $6,121 - $11,456
5,616 Added 9.43%
65,202 $82,000
Q3 2022

Nov 14, 2022

SELL
$1.55 - $3.01 $84,431 - $163,960
-54,472 Reduced 47.76%
59,586 $96,000
Q2 2022

Aug 15, 2022

BUY
$1.39 - $3.12 $100,271 - $225,070
72,138 Added 172.08%
114,058 $225,000
Q1 2022

May 16, 2022

SELL
$2.6 - $4.17 $247,715 - $397,296
-95,275 Reduced 69.44%
41,920 $127,000
Q4 2021

Feb 14, 2022

SELL
$3.64 - $7.78 $252,193 - $539,029
-69,284 Reduced 33.55%
137,195 $499,000
Q3 2021

Nov 15, 2021

SELL
$6.01 - $8.71 $738,701 - $1.07 Million
-122,912 Reduced 37.31%
206,479 $1.63 Million
Q2 2021

Aug 11, 2021

BUY
$6.02 - $9.64 $1.19 Million - $1.91 Million
197,792 Added 150.3%
329,391 $2.4 Million
Q1 2021

May 17, 2021

BUY
$9.17 - $14.8 $196,210 - $316,675
21,397 Added 19.42%
131,599 $1.24 Million
Q4 2020

Feb 16, 2021

BUY
$8.92 - $13.29 $107,378 - $159,985
12,038 Added 12.26%
110,202 $1.24 Million
Q3 2020

Nov 16, 2020

BUY
$9.94 - $16.59 $606,499 - $1.01 Million
61,016 Added 164.25%
98,164 $1.05 Million
Q2 2020

Aug 14, 2020

BUY
$12.07 - $19.34 $196,475 - $314,816
16,278 Added 78.0%
37,148 $564,000
Q1 2020

May 15, 2020

SELL
$12.5 - $22.04 $82,662 - $145,750
-6,613 Reduced 24.06%
20,870 $324,000
Q4 2019

Feb 14, 2020

BUY
$11.42 - $22.19 $151,920 - $295,193
13,303 Added 93.82%
27,483 $569,000
Q3 2019

Nov 14, 2019

SELL
$14.74 - $22.28 $68,349 - $103,312
-4,637 Reduced 24.64%
14,180 $257,000
Q2 2019

Aug 16, 2019

BUY
$18.35 - $30.34 $345,291 - $570,907
18,817 New
18,817 $368,000

Others Institutions Holding FIXX

About Homology Medicines, Inc.


  • Ticker FIXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 57,402,000
  • Description
  • Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...
More about FIXX
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.